Invasive Group A Streptococcus Flashcards

1
Q

Is iGAS nationally notifiable?

A

Yes, since 1 July 2022.

Notifiable in QLD (2005), NT (2011), SA (2021), WA (2021).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What organism causes iGAS?

A

Group A Streptococcus (S. pyogenes)

Gram +, B-haemolytic bacteria. >240 strains

Classified by emm-typing (variable region of the emm gene)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is iGAS?

A

Invasive Group A Streptococcus. I.e. GAS disease that is invasive - detected in normally sterile site.

Blood, CSF, pleural fluid, peritoneal fluid, pericardial fluid, joint fluid, bone, bone marrow.

Internal organs excluding lungs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the reservoir of iGAS?

A

Humans only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the mode of transmission for iGAS?

A
  • Direct person-person
  • Droplet spread
  • Direct contact with patients/carriers (saliva, wound discharge, nasal secertions
  • Fomites (rarely)

People with GAS disease (e.g. impetigo, pharyngitis) are much more likely to transmit the bacteria to others than asymptomatic carriers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the clinical presentation of GAS (not iGAS)?

A

Spectrum of disease (mild to severe):

  • ASx carriage (common: 5-30%)
  • Scarlet fever, tonsilitis, pharyngitis
  • Impetigo or cellulitis
  • Complications: ARF, PSGN
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the clinical presentation of iGAS?

A
  • Septicaemia
  • Pneumonia/empyema
  • Osteomyelitis
  • Septic arthritis
  • Pericarditis
  • Peritonitis
  • Meningitis
  • Puerperal sepsis
  • Streptococcal toxic shock syndrome (STSS)
  • Necrotising fasciitis.

High CFR with invasive disease - 7%.; TSS 23%; Nec fasc 70%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Who is at increased risk of disease?

A
  • Elderly, infants, young children
  • Birthing person-neonate pairs
  • Chronic disease (diabetes, heart dz, haemodialysis)
  • Immunocompromised
  • Household contacts of a case
  • Institutional settings (CC, RACF etc)
  • Overcrowded houses (First Nations, Pasifika)
  • PWID
  • Poor hygiene environments

PWID = people who inject drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the case definition for iGAS?

A

Confirmed cases - lab definitive: culture/PCR from normally sterile site.

Probable case - lab suggestive + clinical suggestive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How is iGAS diagnosed?

A

Culture or PCR from normally sterile site.

Typing at reference lab e.g. MDU/VIDRL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the iGAS incubation period?

A

Not well-defined.

Pharyngitis - 1-3 days
Impetigo - 7-10 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the iGAS infectious period?

A

7 days before onset to 24 hours after appropriate antibiotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the outbreak definition for iGAS?

A

2 + epi linked cases within 30 days.

If identical typing then confirmed outbreak, otherwise suspected.

An outbreak is a cluster with a suspected common source.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the definition of an institutional cluster for iGAS?

A

Confirmed: 2 + epi linked cases in 3 months + identical molecular type where cases not HH contacts.

Suspected: as above without typing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the routine prevention activities?

A

No vaccine

Primordial prevention - social determinants - reduce overcrowded housing, improve health hardware, education on hygiene practices.

Primary prevention - improve skin health, early detection and treatment of sore throat/impetigo in high-risk people.

Institutional settings - follow IPC practices, encourage basic hygiene practices

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What resources are available for iGAS management?

A

SoNG, DH guidelines.

17
Q

What is the case management for iGAS?

A
  • Liaise with treating clinician
  • Isolation/restriction - standard/droplet precautions until 24 hours after appropriate ABx
  • Identify if high-risk person, group or in a high-risk facility
  • Determine if part of neonate-maternal pair or institutional / HH cluster
  • Education re: disease and transmission
18
Q

What are the types of contacts or iGAS?

A
  • Birthing person-neonate pairs
  • Household or household-like
  • Institutional
  • Airway exposed healthcare workers
19
Q

How are iGAS contacts managed?

A
  • Education re: transmission and preventative measures
  • Routine screening and clearance ABx not recommended
  • Clearance ABx for mother-neotnate pair
  • No clearance ABx for HH, institutional or airway-exposed healthcare contacts (case-by-case basis)
  • Restriction not routinely recommended
20
Q

How are iGAS outbreaks managed?

A

HH clusters as above.

Institutional outbreak (RACF, CC, maternity ward):
* Inform contacts
* Arrange typing at ref lab (MDU)
* If confirmed offer clearance ABx for all residents and staff
* Review IPC (esp. cleaning and hand hygiene)
* Active surveillance for new cases
* Screening not usually indicated

21
Q

What are considerations for iGAS clusters in First Nations households / communities?

A
  • Refer to ACCHO/AMS for culturally appropriate Ax and F/U
  • Develop & implement health education program with culturally appropriate governance structure
  • Active participation in decisions by AHWs/AHPs, ACCHOs, community members
22
Q

What is the antimicrobial sensitivity of GAS?

A

Universally penicillin sensitive.

Other agents can be used due to allergies - vanc, macrolides, trimethoprim/sulfamethoxazole, clindamycin

23
Q

What environmental controls are required for iGAS?

A

Not routinely required.

24
Q

For which contacts are chemoprophylaxis routinely provided?

A

Birthing person-neonate pairs - where the birthing person or neonate develop iGAS disease during the first 28 days after birth.

Routine provision of ABx for chemoprophylaxis to all close contacts of a single case is generally not recommended due to limited evidence of its efficacy.

Chemoprophylaxis can be considered for contacts with additional risk factors on a case-by-case basis.

25
Q

What education should be provide to contacts?

A
  • Close contacts at higher risk up to 30 days following contact with case
  • Symptoms to monitor for
  • If symptoms of GAS&raquo_space; non-urgent medical attention
  • If symptoms of iGAS&raquo_space; immediate medical attention
26
Q

What are special situations where chemoprophylaxis may be required?

A

Household clusters and institutional settings.

Household cluster = 2 or more cases within 30 days of symptoms in initial case

Institutional cluster = 2 or more epidemiologically linked cases within 3 months

27
Q

What are some facts about Aboriginal and Torres Strait Islander people in relation to iGAS?

A
  • Higher rates compared to non-Indigenous
  • Increased risk of tranmission due to overcrowding, inadequate housing, barriers to care
  • Higher burden of comorbid conditions
28
Q

How should clusters of iGAS be managed in Aboriginal and Torres Strait Islander communities?

A
  • Aboriginal Community Controlled Health Service / Aboriginal Medical Service
  • Culturally approriate follow-up, care, educational resources